Navigation Links
The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP'
Date:12/13/2007

WELLINGTON, Fla., Dec. 13 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.U) (http://www.QuantumMD.com) today announced that it has completed its registered public offering, raising $13.2 million in gross proceeds. The Company further announced that it has initiated trading on the American Stock Exchange (AMEX) of the Units registered in the Offering under the symbol "QGP.U." In addition, Quantum common shares, formerly traded on the OTC Bulletin Board under the symbol "QNTM," are now also trading on the AMEX under the symbol "QGP." Paulson Investment Company, a wholly owned subsidiary of Paulson Capital Corp. (Nasdaq: PLCC), acted as the lead manager on the offering, and Newbridge Securities Corporation and Neidiger Tucker Bruner, Inc. acted as co-managers.

The offering consisted of 1.2 million Units with an initial Unit offering price of $11.00 per Unit. Each Unit consists of three shares of common stock, two seven year non-callable Class A Warrants and two seven year non-callable Class B Warrants. Each Class A Warrant entitles its holder to purchase one share of common stock at an exercise price of $7.00 per share. Each Class B Warrant entitles its holder to purchase one share of common stock at an exercise price of $11.00 per share. Neither the Class A Warrant nor the Class B Warrant is subject to redemption.

The Units, trading under the symbol "QGP.U," will be broken up in their component parts and will begin trading separately on or about Monday, January 14, 2008, under the symbols "QGP," "QGP.WS.A" and "QGP.WS.B," respectively. Once separate trading in the common stock and Warrants begins, trading in the Units will cease and the Units will be delisted.

Quantum intends to use the net proceeds from this offering to further develop its medical service provider networks and management support services, repay debt, expand its technology platform, pay accrued compensation to its executive management and for general working capital purposes.

A registration statement related to these securities was filed and declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there by any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Offers may only be made by means of a written prospectus. A copy of the final prospectus relating to the offering may be obtained from: Paulson Investment Company, Inc., 811 SW Naito Parkway, Suite 200, Portland, Oregon 97204.

The Quantum Group, Inc., a Wellington, Florida-based company, through its subsidiary companies, including Renaissance Health System of Florida, Inc. (RHS) (http://www.RHSFL.com), offers administrative and support business solutions for health maintenance organizations that market Medicare Advantage managed healthcare plans and to healthcare providers in the state of Florida. Through its growing number of nearly 1,600 contracted physicians and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Quantum light beams good for fast technology
2. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
3. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
4. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
5. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
6. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
7. Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007
8. The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM)
9. Congress Declares Long Term Care Awareness Week - Long Term Care Group, Inc. Continues Related Work
10. Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 2007
11. Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: